您的位置: 首页 > 农业专利 > 详情页

MODIFIED RNAi AGENTS
专利权人:
Alnylam Pharmaceuticals; Inc.
发明人:
Kallanthottathil G. RAJEEV,Tracy ZIMMERMANN,Muthiah MANOHARAN,Martin MAIER,Satyanarayana KUCHIMANCHI,Klaus CHARISSE
申请号:
US15706389
公开号:
US20180008724A1
申请日:
2017.09.15
申请国别(地区):
US
年份:
2018
代理人:
摘要:
One aspect of the present invention relates to double-stranded RNAi (dsRNA) duplex agent capable of inhibiting the expression of a target gene. The dsRNA duplex comprises one or more motifs of three identical modifications on three consecutive nucleotides in one or both strand, particularly at or near the cleavage site of the strand. Other aspects of the invention relates to pharmaceutical compositions comprising these dsRNA agents suitable for therapeutic use, and methods of inhibiting the expression of a target gene by administering these dsRNA agents, e.g., for the treatment of various disease conditions.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充